BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Talwalkar JA, Lindor KD. Primary biliary cirrhosis. Lancet. 2003;362:53-61. [PMID: 12853201 DOI: 10.1016/s0140-6736(03)13808-1] [Cited by in Crossref: 230] [Cited by in F6Publishing: 61] [Article Influence: 12.1] [Reference Citation Analysis]
Number Citing Articles
1 Lleo A, Marzorati S, Anaya JM, Gershwin ME. Primary biliary cholangitis: a comprehensive overview. Hepatol Int 2017;11:485-99. [PMID: 29164395 DOI: 10.1007/s12072-017-9830-1] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 11.4] [Reference Citation Analysis]
2 Yang XC, Fujino M, Cai SJ, Li SW, Liu C, Li XK. Genetic Polymorphisms of Cytotoxic T-Lymphocyte Antigen 4 in Primary Biliary Cholangitis: A Meta-Analysis. J Immunol Res 2017;2017:5295164. [PMID: 28642883 DOI: 10.1155/2017/5295164] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
3 Talwalkar JA. Current and emerging surrogate markers of hepatic fibrosis in primary biliary cirrhosis. Liver Int 2008;28:761-3. [PMID: 18647139 DOI: 10.1111/j.1478-3231.2008.01761.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
4 Wang Z, Qian R, Wang Y, Mo L, Ju B, Hu N, Wang P, He L, Wang J. QTc interval prolongation in the patients with primary biliary cholangitis. Ann Noninvasive Electrocardiol 2021;:e12925. [PMID: 34854522 DOI: 10.1111/anec.12925] [Reference Citation Analysis]
5 Ichiki Y, Selmi C, Shimoda S, Ishibashi H, Gordon SC, Gershwin ME. Mitochondrial antigens as targets of cellular and humoral auto-immunity in primary biliary cirrhosis. Clin Rev Allergy Immunol 2005;28:83-91. [PMID: 15879615 DOI: 10.1385/CRIAI:28:2:083] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
6 Mantaka A, Koulentaki M, Chlouverakis G, Enele-Melono JM, Darivianaki A, Tzardi M, Kouroumalis EA. Primary biliary cirrhosis in a genetically homogeneous population: disease associations and familial occurrence rates. BMC Gastroenterol. 2012;12:110. [PMID: 22898439 DOI: 10.1186/1471-230x-12-110] [Cited by in Crossref: 27] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
7 Hohenester S, Oude-Elferink RP, Beuers U. Primary biliary cirrhosis. Semin Immunopathol. 2009;31:283-307. [PMID: 19603170 DOI: 10.1007/s00281-009-0164-5] [Cited by in Crossref: 114] [Cited by in F6Publishing: 96] [Article Influence: 8.8] [Reference Citation Analysis]
8 Gao L, Tian X, Liu B, Zhang F. The value of antinuclear antibodies in primary biliary cirrhosis. Clin Exp Med. 2008;8:9-15. [PMID: 18385935 DOI: 10.1007/s10238-008-0150-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
9 Zhang W, Ono Y, Miyamura Y, Bowlus CL, Gershwin ME, Maverakis E. T cell clonal expansions detected in patients with primary biliary cirrhosis express CX3CR1. J Autoimmun. 2011;37:71-78. [PMID: 21636249 DOI: 10.1016/j.jaut.2011.05.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
10 Busatto P, Blasi F, Casanova F, Selmi C, Centanni S, Zuin M. Lack of PBC-specific antimitochondrial antibodies in patients with Chlamydia pneumoniae infection. J Gastroenterol Hepatol 2005;20:1626-7. [PMID: 16174090 DOI: 10.1111/j.1440-1746.2005.03941.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
11 Pausch J, Gatzen M. [Treatment of cholestatic hepatic diseases: more than the substitution of fat soluble vitamins?]. Internist (Berl) 2006;47:1239-40, 1242-4. [PMID: 17077981 DOI: 10.1007/s00108-006-1732-6] [Reference Citation Analysis]
12 Nagao Y, Sata M. Disappearance of Oral Lichen Planus After Liver Transplantation for Primary Biliary Cirrhosis and Immunosuppressive Therapy in a 63-year-Old Japanese Woman. Hepat Mon 2014;14:e16310. [PMID: 24734093 DOI: 10.5812/hepatmon.16310] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
13 Liu X, Fassett J, Wei Y, Chen Y. Regulation of DDAH1 as a Potential Therapeutic Target for Treating Cardiovascular Diseases. Evid Based Complement Alternat Med 2013;2013:619207. [PMID: 23878601 DOI: 10.1155/2013/619207] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
14 Tanaka A. Current understanding of primary biliary cholangitis. Clin Mol Hepatol 2021;27:1-21. [PMID: 33264835 DOI: 10.3350/cmh.2020.0028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Yin YF, Zhang X. B cell depletion in treating primary biliary cirrhosis: Pros and cons. World J Gastroenterol 2012; 18(30): 3938-3940 [PMID: 22912543 DOI: 10.3748/wjg.v18.i30.3938] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
16 Zhong B, Strnad P, Selmi C, Invernizzi P, Tao GZ, Caleffi A, Chen M, Bianchi I, Podda M, Pietrangelo A. Keratin variants are overrepresented in primary biliary cirrhosis and associate with disease severity. Hepatology. 2009;50:546-554. [PMID: 19585610 DOI: 10.1002/hep.23041] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 2.7] [Reference Citation Analysis]
17 Koksal D, Koksal AS, Gurakar A. Pulmonary Manifestations among Patients with Primary Biliary Cirrhosis. J Clin Transl Hepatol 2016;4:258-62. [PMID: 27777894 DOI: 10.14218/JCTH.2016.00024] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
18 Mencin A, Kluwe J, Schwabe RF. Toll-like receptors as targets in chronic liver diseases. Gut. 2009;58:704-720. [PMID: 19359436 DOI: 10.1136/gut.2008.156307] [Cited by in Crossref: 225] [Cited by in F6Publishing: 226] [Article Influence: 17.3] [Reference Citation Analysis]
19 Doycheva I, Chen C, Pan JJ, Levy C. Asymptomatic primary biliary cirrhosis is not associated with increased frequency of cardiovascular disease. World J Hepatol 2011; 3(4): 93-98 [PMID: 21603031 DOI: 10.4254/wjh.v3.i4.93] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
20 Zhu GQ, Shi KQ, Huang S, Huang GQ, Lin YQ, Zhou ZR, Braddock M, Chen YP, Zheng MH. Network meta-analysis of randomized controlled trials: efficacy and safety of UDCA-based therapies in primary biliary cirrhosis. Medicine (Baltimore) 2015;94:e609. [PMID: 25789951 DOI: 10.1097/MD.0000000000000609] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
21 Keane JT, Elangovan H, Stokes RA, Gunton JE. Vitamin D and the Liver-Correlation or Cause? Nutrients 2018;10:E496. [PMID: 29659559 DOI: 10.3390/nu10040496] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 9.3] [Reference Citation Analysis]
22 Iwadate H, Ohira H, Saito H, Takahashi A, Rai T, Takiguchi J, Sasajima T, Kobayashi H, Watanabe H, Sato Y. A case of primary biliary cirrhosis complicated by Behçet’s disease and palmoplantar pustulosis. World J Gastroenterol 2006; 12(13): 2136-2138 [PMID: 16610072 DOI: 10.3748/wjg.v12.i13.2136] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
23 Ali AH, Carey EJ, Lindor KD. Recent advances in the development of farnesoid X receptor agonists. Ann Transl Med. 2015;3:5. [PMID: 25705637 DOI: 10.3978/j.issn.2305-5839] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
24 Selmi C, Maria Papini A, Pugliese P, Claudia Alcaro M, Gershwin ME. Environmental pathways to autoimmune diseases: the cases of primary biliary cirrhosis and multiple sclerosis. Arch Med Sci. 2011;7:368-380. [PMID: 22295019 DOI: 10.5114/aoms.2011.23398] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
25 Lin RP. Changes in serum levels of anti-mitochondrial antibody subtypes, liver function indexes, and immunological indexes in patients with primary biliary cirrhosis. Shijie Huaren Xiaohua Zazhi 2017; 25(4): 364-368 [DOI: 10.11569/wcjd.v25.i4.364] [Reference Citation Analysis]
26 Tsuda M, Ambrosini YM, Zhang W, Yang GX, Ando Y, Rong G, Tsuneyama K, Sumida K, Shimoda S, Bowlus CL, Leung PS, He XS, Coppel RL, Ansari AA, Lian ZX, Gershwin ME. Fine phenotypic and functional characterization of effector cluster of differentiation 8 positive T cells in human patients with primary biliary cirrhosis. Hepatology 2011;54:1293-302. [PMID: 21735469 DOI: 10.1002/hep.24526] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
27 Dohmen K, Onohara SY, Harada S. Effects of Switching from Fenofibrate to Pemafibrate for Asymptomatic Primary Biliary Cholangitis. Korean J Gastroenterol 2021;78:227-34. [PMID: 34697277 DOI: 10.4166/kjg.2021.092] [Reference Citation Analysis]
28 Joshita S, Umemura T, Tanaka E, Ota M. Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis. J Immunol Res. 2017;2017:3073504. [PMID: 28255561 DOI: 10.1155/2017/3073504] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
29 Khanna A, Jones DE. Novel strategies and therapeutic options for the management of primary biliary cholangitis. Therap Adv Gastroenterol 2017;10:791-803. [PMID: 29051789 DOI: 10.1177/1756283X17728669] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
30 Ali AH, Carey EJ, Lindor KD. Recent advances in the development of farnesoid X receptor agonists. Ann Transl Med. 2015;3:5. [PMID: 25705637 DOI: 10.3978/j.issn.2305-5839.2014.12.06] [Cited by in F6Publishing: 76] [Reference Citation Analysis]
31 Houts CR, Morlock R, Blum SI, Edwards MC, Wirth RJ. Scale development with small samples: a new application of longitudinal item response theory. Qual Life Res 2018;27:1721-34. [PMID: 29423756 DOI: 10.1007/s11136-018-1801-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
32 Rudic JS, Poropat G, Krstic MN, Bjelakovic G, Gluud C. Ursodeoxycholic acid for primary biliary cirrhosis. Cochrane Database Syst Rev. 2012;12:CD000551. [PMID: 23235576 DOI: 10.1002/14651858.CD000551] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
33 Saverino D, Simone R, Bagnasco M, Pesce G. The soluble CTLA-4 receptor and its role in autoimmune diseases: an update. Auto Immun Highlights 2010;1:73-81. [PMID: 26000110 DOI: 10.1007/s13317-010-0011-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
34 Joshita S, Umemura T, Tanaka E, Ota M. Genetics and epigenetics in the pathogenesis of primary biliary cholangitis. Clin J Gastroenterol 2018;11:11-8. [PMID: 29159718 DOI: 10.1007/s12328-017-0799-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.6] [Reference Citation Analysis]
35 Nardi N, Brito-Zerón P, Ramos-Casals M, Aguiló S, Cervera R, Ingelmo M, Font J. Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sjögren's syndrome: prevalence and clinical significance in 335 patients. Clin Rheumatol 2006;25:341-6. [PMID: 16249826 DOI: 10.1007/s10067-005-0059-3] [Cited by in Crossref: 62] [Cited by in F6Publishing: 47] [Article Influence: 3.6] [Reference Citation Analysis]
36 Kwok J, Jones B. Unnecessary repeat requesting of tests: an audit in a government hospital immunology laboratory. J Clin Pathol. 2005;58:457-462. [PMID: 15858114 DOI: 10.1136/jcp.2004.021691] [Cited by in Crossref: 60] [Cited by in F6Publishing: 43] [Article Influence: 3.5] [Reference Citation Analysis]
37 Gershwin ME, Selmi C, Worman HJ, Gold EB, Watnik M, Utts J, Lindor KD, Kaplan MM, Vierling JM; USA PBC Epidemiology Group. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology 2005;42:1194-202. [PMID: 16250040 DOI: 10.1002/hep.20907] [Cited by in Crossref: 395] [Cited by in F6Publishing: 327] [Article Influence: 23.2] [Reference Citation Analysis]
38 Takahashi N, Saeki T, Komatsuda A, Munemura C, Fukui T, Imai N, Homma N, Hatta T, Samejima KI, Fujimoto T, Omori H, Ito Y, Nishikawa Y, Kobayashi M, Morikawa Y, Fukushima S, Yokoi S, Mikami D, Kasuno K, Kimura H, Nemoto T, Nakamoto Y, Sada K, Sugai M, Naiki H, Yoshida H, Narita I, Saito Y, Iwano M. Tubulointerstitial Nephritis with IgM-Positive Plasma Cells. J Am Soc Nephrol 2017;28:3688-98. [PMID: 28794148 DOI: 10.1681/ASN.2016101074] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
39 Sinclair D, Spedding A, Young R. Can the laboratory affect the investigation and diagnosis of primary biliary cirrhosis? J Clin Pathol 2006;59:360-2. [PMID: 16461570 DOI: 10.1136/jcp.2005.028936] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
40 Tajiri K, Shimizu Y. Liver physiology and liver diseases in the elderly. World J Gastroenterol 2013; 19(46): 8459-8467 [PMID: 24379563 DOI: 10.3748/wjg.v19.i46.8459] [Cited by in CrossRef: 73] [Cited by in F6Publishing: 50] [Article Influence: 8.1] [Reference Citation Analysis]
41 Ohkura Y, Sasaki K, Matsuda M, Hashimoto M, Watanabe G. Long-term prognosis after resection of cryptogenic hepatocellular carcinoma. BMC Surg 2015;15:115. [PMID: 26475278 DOI: 10.1186/s12893-015-0099-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
42 Cazzagon N, Dal Lin C, Famoso G, Montisci R, Franceschet I, Floreani A, Tona F. Coronary flow reserve in patients with primary biliary cholangitis. Dig Liver Dis 2019;51:542-8. [PMID: 30448459 DOI: 10.1016/j.dld.2018.10.016] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Yoshida EM, Riley M, Arbour LT. Autoimmune liver disease and the Canadian First Nations Aboriginal Communities of British Columbia’s Pacific Northwest. World J Gastroenterol 2006; 12(23): 3625-3627 [PMID: 16773676 DOI: 10.3748/wjg.v12.i23.3625] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
44 Kumagi T, Heathcote EJ. Primary biliary cirrhosis. Orphanet J Rare Dis 2008;3:1. [PMID: 18215315 DOI: 10.1186/1750-1172-3-1] [Cited by in Crossref: 67] [Cited by in F6Publishing: 57] [Article Influence: 4.8] [Reference Citation Analysis]
45 Reshetnyak VI. Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis. World J Gastroenterol 2015; 21(25): 7683-7708 [PMID: 26167070 DOI: 10.3748/wjg.v21.i25.7683] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
46 Allocca M, Crosignani A, Gritti A, Ghilardi G, Gobatti D, Caruso D, Zuin M, Podda M, Battezzati PM. Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis. Gut. 2006;55:1795-1800. [PMID: 16632556 DOI: 10.1136/gut.2005.079814] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 3.8] [Reference Citation Analysis]
47 Selmi C, Ichiki Y, Invernizzi P, Podda M, Gershwin ME. The enigma of primary biliary cirrhosis. Clin Rev Allergy Immunol 2005;28:73-81. [PMID: 15879614 DOI: 10.1385/CRIAI:28:2:073] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
48 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2006; 14(7): 702-708 [DOI: 10.11569/wcjd.v14.i7.702] [Reference Citation Analysis]
49 Yamaguchi S, Maruyama T, Wakino S, Tokuyama H, Hashiguchi A, Tada S, Homma K, Monkawa T, Thomas J, Miyashita K. A case of severe osteomalacia caused by Tubulointerstitial nephritis with Fanconi syndrome in asymptomotic primary biliary cirrhosis. BMC Nephrol. 2015;16:187. [PMID: 26554665 DOI: 10.1186/s12882-015-0184-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
50 Rudic JS, Poropat G, Krstic MN, Bjelakovic G, Gluud C. Ursodeoxycholic acid for primary biliary cirrhosis. Cochrane Database Syst Rev 2012;12:CD000551. [PMID: 23235576 DOI: 10.1002/14651858.CD000551.pub3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 33] [Article Influence: 1.7] [Reference Citation Analysis]
51 Crosignani A, Battezzati PM, Invernizzi P, Selmi C, Prina E, Podda M. Clinical features and management of primary biliary cirrhosis. World J Gastroenterol 2008; 14(21): 3313-3327 [PMID: 18528929 DOI: 10.3748/wjg.14.3313] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
52 Floreani A, Infantolino C, Franceschet I, Tene IM, Cazzagon N, Buja A, Baldo V, Gershwin ME, Gervasi MT. Pregnancy and primary biliary cirrhosis: a case-control study. Clin Rev Allergy Immunol 2015;48:236-42. [PMID: 24984967 DOI: 10.1007/s12016-014-8433-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
53 Mo C, Lu Y, Deng Y, Wang J, Xie L, Li T, He Y, Qin X, Li S. Lack of association between vitamin D receptor gene ApaI, BsmI, and TaqI polymorphisms and primary biliary cirrhosis risk: a meta-analysis. Tumour Biol. 2014;35:4913-4920. [PMID: 24526415 DOI: 10.1007/s13277-014-1645-2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
54 Gangeri L, Bosisio M, Brunelli C, Tamburini M, Serafin P, Clerici CA, Caraceni A, Mazzaferro V. Phenomenology and emotional impact of neuropsychiatric symptoms in orthotopic liver transplant for hepatocellular carcinoma. Transplant Proc 2007;39:1564-8. [PMID: 17580189 DOI: 10.1016/j.transproceed.2007.02.071] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
55 Biagini MR, Tozzi A, Marcucci R, Paniccia R, Fedi S, Milani S, Galli A, Ceni E, Capanni M, Manta R, Abbate R, Surrenti C. Hyperhomocysteinemia and hypercoagulability in primary biliary cirrhosis. World J Gastroenterol 2006; 12(10): 1607-1612 [PMID: 16570355 DOI: 10.3748/wjg.v12.i10.1607] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
56 Kanda T, Yokosuka O, Kojima H, Imazeki F, Nagao K, Tatsuno I, Saito Y, Saisho H. Severe hypercholesterolemia associated with primary biliary cirrhosis in a 44-year-old Japanese woman. World J Gastroenterol 2004; 10(17): 2607-2608 [PMID: 15300919 DOI: 10.3748/wjg.v10.i17.2607] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
57 Jazia EB, Khalifa M, Abdelkader AB, Kaabia N, Ghannouchi N, Braham A, Letaief A, Bahri F. A case of primary biliary cirrhosis associated with pernicious anemia: a case report. Cases J 2010;3:11. [PMID: 20148139 DOI: 10.1186/1757-1626-3-11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
58 Wang H, Xu H, Wang X, Wu R, Gao X, Jin Q, Niu J. Red Blood Cell Distribution Width to Platelet Ratio is Related to Histologic Severity of Primary Biliary Cirrhosis. Medicine (Baltimore) 2016;95:e3114. [PMID: 26986159 DOI: 10.1097/MD.0000000000003114] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
59 Ferreira-Gonzalez S, Lu WY, Raven A, Dwyer B, Man TY, O'Duibhir E, Lewis PJS, Campana L, Kendall TJ, Bird TG, Tarrats N, Acosta JC, Boulter L, Forbes SJ. Paracrine cellular senescence exacerbates biliary injury and impairs regeneration. Nat Commun. 2018;9:1020. [PMID: 29523787 DOI: 10.1038/s41467-018-03299-5] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 10.8] [Reference Citation Analysis]
60 Siddique A, Kowdley KV. Approach to a patient with elevated serum alkaline phosphatase. Clin Liver Dis. 2012;16:199-229. [PMID: 22541695 DOI: 10.1016/j.cld.2012.03.012] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
61 Lasker JN, Sogolow ED, Sharim RR. The role of an online community for people with a rare disease: content analysis of messages posted on a primary biliary cirrhosis mailinglist. J Med Internet Res 2005;7:e10. [PMID: 15829472 DOI: 10.2196/jmir.7.1.e10] [Cited by in Crossref: 125] [Cited by in F6Publishing: 88] [Article Influence: 7.4] [Reference Citation Analysis]
62 Xu P, Peng H, Huang T. Unsupervised learning of mixture regression models for longitudinal data. Computational Statistics & Data Analysis 2018;125:44-56. [DOI: 10.1016/j.csda.2018.03.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
63 Furuta K, Sato S, Yamauchi T, Ozawa T, Harada M, Kakumu S. Intrahepatic gene expression profiles in chronic hepatitis B and autoimmune liver disease. J Gastroenterol. 2008;43:866-874. [PMID: 19012040 DOI: 10.1007/s00535-008-2237-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
64 Nguyen DL, Juran BD, Lazaridis KN. Primary biliary cirrhosis. Best Pract Res Clin Gastroenterol. 2010;24:647-654. [PMID: 20955967 DOI: 10.1016/j.bpg.2010.07.006] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
65 Liu X, Hou L, Xu D, Chen A, Yang L, Zhuang Y, Xu Y, Fassett JT, Chen Y. Effect of asymmetric dimethylarginine (ADMA) on heart failure development. Nitric Oxide 2016;54:73-81. [PMID: 26923818 DOI: 10.1016/j.niox.2016.02.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.7] [Reference Citation Analysis]
66 Jung HE, Jang JY, Jeong SW, Kim JN, Jang HY, Cho YJ, Woo SA, Lee SH, Kim SG, Cha SW. Prognostic indicators in primary biliary cirrhosis: significance of revised IAHG (International Autoimmune Hepatitis Group) score. Clin Mol Hepatol. 2012;18:375-382. [PMID: 23323253 DOI: 10.3350/cmh.2012.18.4.375] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
67 Moreira RK, Revetta F, Koehler E, Washington MK. Diagnostic utility of IgG and IgM immunohistochemistry in autoimmune liver disease. World J Gastroenterol 2010; 16(4): 453-457 [PMID: 20101770 DOI: 10.3748/wjg.v16.i4.453] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
68 Omagari K, Hazama H, Kohno S. Enzyme inhibition assay for pyruvate dehydrogenase complex: Clinical utility for the diagnosis of primary biliary cirrhosis. World J Gastroenterol 2005; 11(43): 6735-6739 [PMID: 16425376 DOI: 10.3748/wjg.v11.i43.6735] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
69 Moreira RK, Chopp W, Washington MK. The concept of hepatic artery-bile duct parallelism in the diagnosis of ductopenia in liver biopsy samples. Am J Surg Pathol 2011;35:392-403. [PMID: 21317711 DOI: 10.1097/PAS.0b013e3182082ef6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]